This is a special glue made from your own blood (autologous) or from a donor. It helps doctors seal up small cuts or wounds. It works by using your body's natural clotting process to stick tissues together and help stop bleeding.
Every report comes from a Lived member, sent anonymously.
Have you tried Fibrin Glue for Rectal Fistula?
Fibrin glue, also called fibrin sealant or fibrin tissue adhesive, is a surgical product that helps control oozing blood and hold tissues together during an operation. It is not a medicine anyone takes at home: the surgeon applies it directly to tissue in the operating room. It is used as an add-on when stitches, ties or cautery (sealing small vessels with heat) cannot control bleeding well enough on their own, or are impractical in that spot. Several US products exist, and their approved uses differ. Tisseel is approved for adults and children to help control surgical bleeding and to help prevent leaks where the bowel is reconnected after a temporary colostomy is reversed. Vistaseal is approved to help control mild to moderate surgical bleeding. TachoSil is a patch coated with the same clotting proteins, pressed onto bleeding surfaces in heart, blood vessel and liver surgery. Artiss is used differently: it holds skin grafts in place on burn wounds and tissue flaps in facelift surgery, and is not meant for stopping bleeding. Surgeons also use fibrin glue in other ways, for example to attach a small graft of the eye's surface membrane during pterygium surgery (removal of a fleshy growth over the cornea) instead of using stitches.
Fibrin glue reproduces the last step of the body's own clotting process. It comes as two components. One contains fibrinogen, a clotting protein; the other contains thrombin, an enzyme that converts fibrinogen into fibrin. When the two mix at the surgical site, they form a rubbery fibrin layer that sticks to the tissue surface, plugs small bleeding points and glues tissue edges or grafts together. Tisseel also contains aprotinin, which slows the body's breakdown of the clot so it holds longer. Because the clot forms from the product itself, it still works in people taking heparin or anti-platelet medicines. It is meant for oozing and moderate bleeding. Heavy, fast bleeding from an artery or large vein would simply wash it away, so major bleeding still needs stitches or other surgical control. Over roughly 10 to 14 days the body breaks the fibrin layer down and absorbs it as healing continues.
There is no dose for a patient to follow. The surgical team prepares the two components and applies a thin layer by dripping it through a fine tube or spraying it with a dedicated device, or places the patch form and holds it with pressure. The amount depends on the size of the area to be covered, and it takes a couple of minutes to set. A thin layer matters, because too thick a layer can interfere with healing. Spray devices are run with specific gas types, pressures and distances, and the product is never injected into a blood vessel. These are operating-room safeguards rather than anything a patient needs to manage, but they are part of why the product is used only by trained staff.
Most people notice nothing specific from fibrin glue itself. Bruising, swelling and soreness after the operation come from the surgery and are the usual focus of recovery. In clinical studies of Tisseel, serious reactions linked to the product were uncommon. The most important rare risk is a serious allergic reaction, including anaphylaxis, which has occasionally been fatal. It usually appears while the product is being applied, with signs such as a drop in blood pressure, flushing, wheezing, hives or a fast or slow heart rate, and the anesthesia team watches for it and treats it immediately. Other rare complications include a clot or gas bubble entering the bloodstream if the product reaches a blood vessel or a spray device is used incorrectly, and pressure on nearby nerves when sealants are combined with absorbable bleeding-control materials in tight spaces. Delayed healing at the application site has also been reported.
Tisseel contains aprotinin and should not be used in anyone with a known aprotinin allergy. People who have had aprotinin before, including during earlier heart surgery or from a previous fibrin glue application, have a higher risk of an allergic reaction, so it helps to tell the surgical team about earlier operations and any reaction to surgical products. Vistaseal should not be used in someone who has had anaphylaxis or another severe reaction to human blood products. These products are made from pooled donated human plasma. The plasma comes from licensed US collection centers, and heat and solvent treatment during manufacturing inactivate or remove many viruses, but no process is completely effective, so a small risk of passing on an infection remains. One virus that is hard to remove, parvovirus B19, matters most during pregnancy because it can infect the baby; there are no studies of these products in pregnancy. Anyone who is pregnant, or who declines blood-derived products for personal or religious reasons, should raise it before surgery so the team can weigh alternatives. Few drug interactions apply, because the glue stays where it is placed. Some cleaning solutions containing alcohol or iodine can inactivate it, and oxidized cellulose bleeding-control materials can make Tisseel less effective; the surgical team manages both.
Fibrin glue is usually one small part of a larger operation, and many people only learn it was used from the operative report. Recovery is shaped by the surgery itself rather than by the sealant. Hospitals record its use, especially for aprotinin-containing products, because of the higher allergy risk on later exposure. The benefit varies by operation, and evidence is mixed. In thyroid surgery, trials found less wound drainage, slightly shorter hospital stays and shorter operations, but no change in fluid collections or calcium problems. After lymph node removal for breast cancer, it reduced the amount and duration of drainage only a little and did not prevent fluid build-up. In liver surgery, reviews found the evidence too uncertain to support routine use for reducing blood loss. In pterygium surgery, gluing the graft instead of stitching it may lower the chance of regrowth and shorten surgery, though graft problems such as loosening may be somewhat more common. The glue is absorbed over about two weeks and does not need to be removed. Follow-up is the usual wound or surgical follow-up for the procedure.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Fibrin Glue, what you've noticed, or ask the community a question.